Jami Rubin (EQRx)
Jami Rubin, once fabled for grilling biopharma execs, decamps to head finance at drug pricing disrupter
As Goldman Sachs’ top pharmaceutical analyst, Jami Rubin was known for asking the tough questions. Now, as she takes the lead on EQRx’s mission to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
